RecruitingNot ApplicableNCT07390214

REFOCUS-AF - "RepEat Ablation With AFFERA vs. COntact Force-Guided RF Catheters for Optimal OUtcomes in Symptomatic AF".


Sponsor

Cardioangiologisches Centrum Bethanien

Enrollment

200 participants

Start Date

Dec 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective, randomized (1:1), pilot study enrolling 200 patients with symptomatic atrial fibrillation or atrial tachycardia (AF/AT) recurrence requiring repeat ablation following a single prior PVI procedure for AF.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This trial is comparing two types of catheter ablation tools for people whose atrial fibrillation (AF) or atrial tachycardia (a fast heart rhythm) has come back after a previous ablation procedure. One tool uses a newer system called AFFERA; the other is a traditional contact force-guided radiofrequency catheter. The goal is to find out which approach leads to better outcomes the second time around. **You may be eligible if...** - You are 18 to 85 years old - You have had exactly one previous pulmonary vein isolation (PVI) ablation procedure for AF - Your AF or fast atrial rhythm has returned despite that ablation - You are willing and able to use a heart rhythm monitoring device at home **You may NOT be eligible if...** - You have had more than one previous ablation procedure targeting the pulmonary veins - Your previous ablation treated additional areas beyond the pulmonary veins - Your left atrium (upper left heart chamber) is enlarged (>55mm) - You have had longstanding persistent AF (more than 12 months continuously) - You have had surgical ablation of the heart before Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREDual Energy ablation with RF/PFA: Re-PVI and substrate modification of low voltage areas

Re-PVI

PROCEDURECF-guided RFC: Re-PVI and substrate modification of low voltage areas

Re-PVI


Locations(1)

Cardioangiologisches Centrum Bethanien, Frankfurt am Main, 60431

Frankfurt am Main, Hesse, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07390214


Related Trials